Titre : Benzocycloheptènes

Benzocycloheptènes : Questions médicales fréquentes

Termes MeSH sélectionnés :

Candidemia
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Benzocycloheptènes : Questions médicales les plus fréquentes", "headline": "Benzocycloheptènes : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Benzocycloheptènes : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-11", "dateModified": "2025-03-08", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Benzocycloheptènes" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Hydrocarbures aromatiques polycycliques", "url": "https://questionsmedicales.fr/mesh/D011084", "about": { "@type": "MedicalCondition", "name": "Hydrocarbures aromatiques polycycliques", "code": { "@type": "MedicalCode", "code": "D011084", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D04.615" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Dibenzocycloheptènes", "alternateName": "Dibenzocycloheptenes", "url": "https://questionsmedicales.fr/mesh/D003986", "about": { "@type": "MedicalCondition", "name": "Dibenzocycloheptènes", "code": { "@type": "MedicalCode", "code": "D003986", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D04.615.181.384" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Amitriptyline", "alternateName": "Amitriptyline", "url": "https://questionsmedicales.fr/mesh/D000639", "about": { "@type": "MedicalCondition", "name": "Amitriptyline", "code": { "@type": "MedicalCode", "code": "D000639", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D04.615.181.384.100" } } }, { "@type": "MedicalWebPage", "name": "Butaclamol", "alternateName": "Butaclamol", "url": "https://questionsmedicales.fr/mesh/D002069", "about": { "@type": "MedicalCondition", "name": "Butaclamol", "code": { "@type": "MedicalCode", "code": "D002069", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D04.615.181.384.230" } } }, { "@type": "MedicalWebPage", "name": "Cyproheptadine", "alternateName": "Cyproheptadine", "url": "https://questionsmedicales.fr/mesh/D003533", "about": { "@type": "MedicalCondition", "name": "Cyproheptadine", "code": { "@type": "MedicalCode", "code": "D003533", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D04.615.181.384.340" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Loratadine", "alternateName": "Loratadine", "url": "https://questionsmedicales.fr/mesh/D017336", "about": { "@type": "MedicalCondition", "name": "Loratadine", "code": { "@type": "MedicalCode", "code": "D017336", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D04.615.181.384.340.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Loratadine", "alternateName": "Loratadine", "url": "https://questionsmedicales.fr/mesh/D017336", "about": { "@type": "MedicalCondition", "name": "Loratadine", "code": { "@type": "MedicalCode", "code": "D017336", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D04.615.181.384.340.500" } } }, { "@type": "MedicalWebPage", "name": "Maléate de dizocilpine", "alternateName": "Dizocilpine Maleate", "url": "https://questionsmedicales.fr/mesh/D016291", "about": { "@type": "MedicalCondition", "name": "Maléate de dizocilpine", "code": { "@type": "MedicalCode", "code": "D016291", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D04.615.181.384.380" } } }, { "@type": "MedicalWebPage", "name": "Nortriptyline", "alternateName": "Nortriptyline", "url": "https://questionsmedicales.fr/mesh/D009661", "about": { "@type": "MedicalCondition", "name": "Nortriptyline", "code": { "@type": "MedicalCode", "code": "D009661", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D04.615.181.384.535" } } }, { "@type": "MedicalWebPage", "name": "Protriptyline", "alternateName": "Protriptyline", "url": "https://questionsmedicales.fr/mesh/D011530", "about": { "@type": "MedicalCondition", "name": "Protriptyline", "code": { "@type": "MedicalCode", "code": "D011530", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D04.615.181.384.650" } } } ] } ], "about": { "@type": "MedicalCondition", "name": "Benzocycloheptènes", "alternateName": "Benzocycloheptenes", "code": { "@type": "MedicalCode", "code": "D001567", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Jiatian Li", "url": "https://questionsmedicales.fr/author/Jiatian%20Li", "affiliation": { "@type": "Organization", "name": "State Key Laboratory of Luminescent Materials and Devices, School of Chemistry and Chemical Engineering, South China University of Technology, Guangzhou 510641, P.R. China." } }, { "@type": "Person", "name": "Xiangwen Tan", "url": "https://questionsmedicales.fr/author/Xiangwen%20Tan", "affiliation": { "@type": "Organization", "name": "State Key Laboratory of Luminescent Materials and Devices, School of Chemistry and Chemical Engineering, South China University of Technology, Guangzhou 510641, P.R. China." } }, { "@type": "Person", "name": "Huanfeng Jiang", "url": "https://questionsmedicales.fr/author/Huanfeng%20Jiang", "affiliation": { "@type": "Organization", "name": "State Key Laboratory of Luminescent Materials and Devices, School of Chemistry and Chemical Engineering, South China University of Technology, Guangzhou 510641, P.R. China." } }, { "@type": "Person", "name": "Wanqing Wu", "url": "https://questionsmedicales.fr/author/Wanqing%20Wu", "affiliation": { "@type": "Organization", "name": "State Key Laboratory of Luminescent Materials and Devices, School of Chemistry and Chemical Engineering, South China University of Technology, Guangzhou 510641, P.R. China." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Micafungin pharmacodynamics predict clinical outcomes in hospitalized patients with candidemia caused by certain Candida species.", "datePublished": "2023-04-30", "url": "https://questionsmedicales.fr/article/37067155", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/phar.2804" } }, { "@type": "ScholarlyArticle", "name": "A machine learning model for early candidemia prediction in the intensive care unit: Clinical application.", "datePublished": "2024-09-09", "url": "https://questionsmedicales.fr/article/39250466", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1371/journal.pone.0309748" } }, { "@type": "ScholarlyArticle", "name": "Antifungal susceptibility and virulence determinants profile of candida species isolated from patients with candidemia.", "datePublished": "2024-05-21", "url": "https://questionsmedicales.fr/article/38773138", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41598-024-61813-w" } }, { "@type": "ScholarlyArticle", "name": "Development and validation of COVID-19 associated candidemia score (CAC-Score) in ICU patients.", "datePublished": "2022-09-26", "url": "https://questionsmedicales.fr/article/36135336", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/myc.13531" } }, { "@type": "ScholarlyArticle", "name": "Clinical characteristics and prognostic risk factors of candidemia in non-neutropenic patients: a retrospective cohort study.", "datePublished": "2023-10-04", "url": "https://questionsmedicales.fr/article/37792119", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s10096-023-04672-z" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Composés polycycliques", "item": "https://questionsmedicales.fr/mesh/D011083" }, { "@type": "ListItem", "position": 3, "name": "Hydrocarbures aromatiques polycycliques", "item": "https://questionsmedicales.fr/mesh/D011084" }, { "@type": "ListItem", "position": 4, "name": "Benzocycloheptènes", "item": "https://questionsmedicales.fr/mesh/D001567" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Benzocycloheptènes - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Benzocycloheptènes", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-19", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Benzocycloheptènes", "description": "Comment identifier les benzocycloheptènes ?\nQuels tests sont utilisés pour les benzocycloheptènes ?\nLes benzocycloheptènes sont-ils détectables dans le sang ?\nY a-t-il des marqueurs spécifiques pour ces composés ?\nPeut-on utiliser l'imagerie pour les benzocycloheptènes ?", "url": "https://questionsmedicales.fr/mesh/D001567?mesh_terms=Candidemia&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Benzocycloheptènes", "description": "Quels sont les effets secondaires des benzocycloheptènes ?\nLes benzocycloheptènes causent-ils des douleurs ?\nY a-t-il des symptômes neurologiques associés ?\nPeut-on observer des symptômes cutanés ?\nLes benzocycloheptènes affectent-ils le système respiratoire ?", "url": "https://questionsmedicales.fr/mesh/D001567?mesh_terms=Candidemia&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Benzocycloheptènes", "description": "Comment prévenir l'exposition aux benzocycloheptènes ?\nY a-t-il des formations pour manipuler ces composés ?\nQuels sont les risques en milieu industriel ?\nDes réglementations existent-elles pour leur usage ?\nComment évaluer les risques d'exposition ?", "url": "https://questionsmedicales.fr/mesh/D001567?mesh_terms=Candidemia&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Benzocycloheptènes", "description": "Comment traiter une intoxication aux benzocycloheptènes ?\nY a-t-il des antidotes pour ces composés ?\nQuels médicaments peuvent aider en cas d'allergie ?\nLes benzocycloheptènes nécessitent-ils une hospitalisation ?\nComment gérer les effets à long terme ?", "url": "https://questionsmedicales.fr/mesh/D001567?mesh_terms=Candidemia&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Benzocycloheptènes", "description": "Quelles complications peuvent survenir avec ces composés ?\nLes benzocycloheptènes peuvent-ils causer des cancers ?\nY a-t-il des effets sur la reproduction ?\nPeut-on développer des allergies à long terme ?\nLes benzocycloheptènes affectent-ils le système immunitaire ?", "url": "https://questionsmedicales.fr/mesh/D001567?mesh_terms=Candidemia&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Benzocycloheptènes", "description": "Qui est le plus à risque d'exposition ?\nL'âge influence-t-il la sensibilité ?\nY a-t-il des prédispositions génétiques ?\nLes antécédents médicaux jouent-ils un rôle ?\nL'environnement de travail influence-t-il le risque ?", "url": "https://questionsmedicales.fr/mesh/D001567?mesh_terms=Candidemia&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment identifier les benzocycloheptènes ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "L'identification se fait par des techniques de spectroscopie et de chromatographie." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour les benzocycloheptènes ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests de toxicité et d'efficacité sont réalisés en laboratoire." } }, { "@type": "Question", "name": "Les benzocycloheptènes sont-ils détectables dans le sang ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent être détectés par des analyses spécifiques dans des échantillons biologiques." } }, { "@type": "Question", "name": "Y a-t-il des marqueurs spécifiques pour ces composés ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des marqueurs biologiques peuvent indiquer l'exposition à ces composés." } }, { "@type": "Question", "name": "Peut-on utiliser l'imagerie pour les benzocycloheptènes ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'imagerie moléculaire peut aider à visualiser leur distribution dans les tissus." } }, { "@type": "Question", "name": "Quels sont les effets secondaires des benzocycloheptènes ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent provoquer des nausées, des vertiges ou des réactions allergiques." } }, { "@type": "Question", "name": "Les benzocycloheptènes causent-ils des douleurs ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Des douleurs peuvent survenir en cas de toxicité ou d'allergie." } }, { "@type": "Question", "name": "Y a-t-il des symptômes neurologiques associés ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des symptômes comme des maux de tête ou des troubles de la coordination peuvent apparaître." } }, { "@type": "Question", "name": "Peut-on observer des symptômes cutanés ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des éruptions cutanées peuvent survenir en cas de réaction allergique." } }, { "@type": "Question", "name": "Les benzocycloheptènes affectent-ils le système respiratoire ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Une exposition excessive peut entraîner des irritations respiratoires." } }, { "@type": "Question", "name": "Comment prévenir l'exposition aux benzocycloheptènes ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Utiliser des équipements de protection et suivre les protocoles de sécurité en laboratoire." } }, { "@type": "Question", "name": "Y a-t-il des formations pour manipuler ces composés ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des formations spécifiques sont souvent requises pour les chercheurs." } }, { "@type": "Question", "name": "Quels sont les risques en milieu industriel ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Les travailleurs peuvent être exposés à des niveaux élevés sans protection adéquate." } }, { "@type": "Question", "name": "Des réglementations existent-elles pour leur usage ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des réglementations strictes encadrent leur utilisation en laboratoire et en industrie." } }, { "@type": "Question", "name": "Comment évaluer les risques d'exposition ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Des évaluations de risque doivent être effectuées régulièrement dans les environnements de travail." } }, { "@type": "Question", "name": "Comment traiter une intoxication aux benzocycloheptènes ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement inclut l'élimination de l'exposition et des soins symptomatiques." } }, { "@type": "Question", "name": "Y a-t-il des antidotes pour ces composés ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Actuellement, il n'existe pas d'antidote spécifique pour les benzocycloheptènes." } }, { "@type": "Question", "name": "Quels médicaments peuvent aider en cas d'allergie ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des antihistaminiques peuvent être utilisés pour traiter les réactions allergiques." } }, { "@type": "Question", "name": "Les benzocycloheptènes nécessitent-ils une hospitalisation ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Une hospitalisation peut être nécessaire en cas de symptômes graves." } }, { "@type": "Question", "name": "Comment gérer les effets à long terme ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Un suivi médical régulier est recommandé pour surveiller les effets à long terme." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec ces composés ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications comme des lésions organiques peuvent survenir en cas d'exposition prolongée." } }, { "@type": "Question", "name": "Les benzocycloheptènes peuvent-ils causer des cancers ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Des études suggèrent un potentiel cancérigène, mais des recherches supplémentaires sont nécessaires." } }, { "@type": "Question", "name": "Y a-t-il des effets sur la reproduction ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Des effets néfastes sur la reproduction ont été observés dans certaines études animales." } }, { "@type": "Question", "name": "Peut-on développer des allergies à long terme ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des sensibilisations peuvent se développer avec une exposition répétée." } }, { "@type": "Question", "name": "Les benzocycloheptènes affectent-ils le système immunitaire ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Une exposition prolongée peut altérer la fonction immunitaire, augmentant les infections." } }, { "@type": "Question", "name": "Qui est le plus à risque d'exposition ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les travailleurs en laboratoire et en industrie chimique sont les plus exposés." } }, { "@type": "Question", "name": "L'âge influence-t-il la sensibilité ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les jeunes et les personnes âgées peuvent être plus sensibles aux effets toxiques." } }, { "@type": "Question", "name": "Y a-t-il des prédispositions génétiques ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Certaines prédispositions génétiques peuvent augmenter la sensibilité aux toxines." } }, { "@type": "Question", "name": "Les antécédents médicaux jouent-ils un rôle ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents d'allergies ou de maladies respiratoires augmentent le risque." } }, { "@type": "Question", "name": "L'environnement de travail influence-t-il le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un environnement de travail mal ventilé augmente le risque d'exposition." } } ] } ] }

Sources (168 au total)

Micafungin pharmacodynamics predict clinical outcomes in hospitalized patients with candidemia caused by certain Candida species.

Echinocandins are guideline-preferred therapies for invasive candidiasis (IC). Fixed dosing of echinocandins is commonly used despite variations in body mass index and echinocandin susceptibility. The... Candida isolate results were screened from bloodstream or intraabdominal cultures of hospitalized patients admitted to a quaternary-care teaching hospital. Patients with a first episode of IC who rece... CART-derived micafungin MIC and AUC/MIC breakpoints predicted patient mortality and treatment failure for certain Candida species. These results support the need for further PK/PD studies to optimize ...

Development and validation of COVID-19 associated candidemia score (CAC-Score) in ICU patients.

The development of candidemia is a highly fatal condition in severe COVID-19 infection.... This study aimed to develop a candidemia prediction score in COVID-19 patient based on the patient's clinical characteristics, and healthcare-related factors during intensive care units (ICU) follow-u... Severe COVID-19 patients hospitalised in ICU in Ankara City Hospital during the one-year period (August 15, 2020, and August 15, 2021) were included. After univariate analysis, multivariate analysis w... Of 1305 COVID-19 ICU patients, 139 had a candidemia episode. According to the final model, four variables, presence of central venous catheter (CVC) (OR 19.07, CI 8.12-44.8, p < .0001), multifocal col... We developed and validated an easy-to-use clinical prediction score for candidemia in severe COVID-19 infection. In COVID-19 ICU patients, the risk of candidemia is high if one of the other risk facto...

The interplay of infectious diseases consultation and antimicrobial stewardship in candidemia outcomes: A retrospective cohort study from 2016 to 2019.

To evaluate the need for mandatory infectious diseases consultation (IDC) for candidemia in the setting of antimicrobial stewardship guidance.... Retrospective cohort study from January 2016 to December 2019.... Academic quaternary-care referral center.... All episodes of candidemia in adults (n = 92), excluding concurrent bacterial infection or death or hospice care within 48 hours.... Primary outcome was all-cause 30-day mortality. Secondary outcomes included guideline-adherence and treatment choice. Guideline-adherence was assessed with the EQUAL... Of 186 episodes of candidemia, 92 episodes in 88 patients were included. Central venous catheters (CVCs) were present in 66 episodes (71.7%) and were the most common infection source (N = 38, 41.3%). ... In the setting of an active antimicrobial stewardship program and high consultation rates, mandatory IDC may not be warranted for candidemia....